- Peptid-Pools

MAGE-A3 Control Pool of 76 peptides with 25µg each peptide derived from a peptide scan (15mers with 11 aa overlap) through Melanoma-associated antigen 3 (MAGEA3) (UniProt ID: P43357) of Homo sapiens (Human) for T cell assay.One unit allows the stimulation of 2,5 x 108 cells. Length of Melanoma-associated antigen 3: 314amino acidsSequence:MPLEQRSQHCKPEEGLEARGEALGLVGAQAPATEEQEAASSSSTLVEVTLGEVPAAESPDPPQSPQGASSLPTTMNYPLWSQSYEDSSNQEEEGPSTFPDLESEFQAALSRKVAELVHFLLLKYRAREPVTKAEMLGSVVGNWQYFFPVIFSKASSSLQLVFGIELMEVDPIGHLYIFATCLGLSYDGLLGDNQIMPKAGLLIIVLAIIAREGDCAPEEKIWEELSVLEVFEGREDSILGDPKKLLTQHFVQENYLEYRQVPGSDPACYEFLWGPRALVETSYVKVLHHMVKISGGPHISYPPLHEWVLREGEE

The Genaxxon Human (SOX2) Peptide Pool comes as a pool of 77 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Transcription factor SOX-2 (UniProtKB - P48431) for T cell assays.One unit allows the stimulation of 2,5 x 108 cells.

Peptide Pool of 125 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) (UniProt ID: P78395) of Homo sapiens (Human). One unit allows the stimulation of 2,5 x 10E8 cells.

The Tetanus Peptide Pool consists of 326 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Tetanus toxin (UniProt ID: P04958) of Clostridium tetani (strain Massachusetts / E88) for T cell assays (e.g. ELISPOT). One unit allows the stimulation of 2,5 x 10E8 cells.

EBV (EBNA-3a) Peptide Pool is a Pool of 234 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Epstein-Barr nuclear antigen 3 (EBNA3a) (UniProt ID: P12977) of Epstein-Barr virus (HHV4) for T cell assays. One pack size allows the stimulation of 2,5 x 10E8 cells.

The M. tuberculosis esxH Peptide-Pool represents 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6-like protein (Swiss-Prot ID: P9WNK3) - EsxH of M. Tuberculosis - strain ATCC 25618 / H37Rv. All peptides are mixed and lyophilized before delivery offering the identified immunodominant epitopes of the tuberculosis bacteria.

CMV pp65 Control Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa phosphoprotein (pp65) (UniProtKB - P06725) of Human cytomegalovirus (HHV-5) frequently used as positive control. 15 nmol (approx. 25µg/peptide) for stimulation of 2.5 x 10E8 cells µg. Length 65 kDa phosphoprotein: 561 amino acidsSequence:MESRGRRCPEMISVLGPISGHVLKAVFSRGDTPVLPHETRLLQTGIHVRVSQPSLILVSQYTPDSTPCHRGDNQLQVQHTYFTGSEVENVSVNVHNPTGRSICPSQEPMSIYVYALPLKMLNIPSINVHHYPSAAERKHRHLPVADAVIHASGKQMWQARLTVSGLAWTRQQNQWKEPDVYYTSAFVFPTKDVALRHVVCAHELVCSMENTRATKMQVIGDQYVKVYLESFCEDVPSGKLFMHVTLGSDVEEDLTMTRNPQPFMRPHERNGFTVLCPKNMIIKPGKISHIMLDVAFTSHEHFGLLCPKSIPGLSISGNLLMNGQQIFLEVQAIRETVELRQYDPVAALFFFDIDLLLQRGPQYSEHPTFTSQYRIQGKLEYRHTWDRHDEGAAQGDDDVWTSGSDSDEELVTTERKTPRVTGGGAMAGASTSAGRKRKSASSATACTSGVMTRGRLKAESTVAPEEDTDEDSDNEIHNPAVFTWPPWQAGILARNLVPMVATVQGQNLKYQEFFWDANDIYRIFAELEGVWQPAAQPKRRRHRQDALPGPCIASTPKKHRG

This peptide pool of the omicron variant B.1.1.529 BA.5 of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) that covers the whole spike glycoprotein with all mutations. Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.The peptides of this product are supplied lyophilized as trifluoro acetate salts. Peptide Scan 15/11Length: 1270 amino acidsMFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLKSYGFQPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT

Peptide pool with 14 peptides that covers all mutations in the Spike Glycoprotein derived from the epsilon variant  B.1.427/B.1.429 of SARS-CoV-2. Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.This peptide pool is supplied lyophilized as trifluoroacetate salt. Peptide sequences included (15 nmol (approx. 25ug)/peptide for stimulation of 2.5 x 10E8 cells):MFVFLVLLPLVSIQC AVLYQGVNCTEVPVA LVLLPLVSIQCVNLT QGVNCTEVPVAIHAD PLVSIQCVNLTTRTQ IQCVNLTTRTQLPPA LGVYYHKNNKSCMES YHKNNKSCMESEFRV NKSCMESEFRVYSSA LDSKVGGNYNYRYRL VGGNYNYRYRLFRKS YNYRYRLFRKSNLKP GTNTSNQVAVLYQGV SNQVAVLYQGVNCTE Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. Protein ID: P0DTC2 (swiss prot) 

This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020.. Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.This peptide pool is supplied lyophilized as trifluoroacetate salt. Peptide sequences included (15 nmol (approx. 25ug)/peptide for stimulation of 2,5 x 108 cells):KVFRSSVLHSTRDLF PFLGVHKNNKSWMES PIGAGICASYQTHTN SSVLHSTRDLFLPFF VHKNNKSWMESEFRV GICASYQTHTNSPRR HSTRDLFLPFFSNVT NKSWMESEFRVYSSA SYQTHTNSPRRARSV DLFLPFFSNVTWFHVMESEFRVYSSANNCT HTNSPRRARSVASQS PFFSNVTWFHVISGT FRVYSSANNCTFEYV LLAGTITSGWTLGAG NVTWFHVISGTNGTK YQAGSTPCNGVKGFN TITSGWTLGAGAALQ FHVISGTNGTKRFDN STPCNGVKGFNCYFPGWTLGAGAALQIPFA SGTNGTKRFDNPVLP NGVKGFNCYFPLQSY GTKRFDNPVLPFNDG GTNTSNQVAVLYQGV VIKVCEFQFCNDPFL SNQVAVLYQGVNCTE CEFQFCNDPFLGVHK AVLYQGVNCTEVPVA FCNDPFLGVHKNNKSQGVNCTEVPVAIHAD Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. Protein ID: P0DTC2 (swiss prot) 

This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron variant B.1.1.529 of SARS-CoV-2. The peptides of this product are supplied lyophilized as trifluoroacetate salts.This pool consists of 80 peptides of the spike protein and covers onlythe mutations of the new omicron variant of SARS-CoV-2 (B.1.1.529). Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS. Peptide sequences - total length: 1273 amino acids DLFLPFFSNVTWFHV; RQIAPGQTGNIADYN; VAVLYQGVNCTEVPV; PFFSNVTWFHVISGT; PGQTGNIADYNYKLP; YQGVNCTEVPVAIHA; NVTWFHVISGTNGTK;GNIADYNYKLPDDFT; QTRAGCLIGAEYVNN; FHVISGTNGTKRFDN; DFTGCVIAWNSNKLD; GCLIGAEYVNNSYEC; VLPFNDGVYFASIEK; CVIAWNSNKLDSKVS;GAEYVNNSYECDIPI; NDGVYFASIEKSNII; WNSNKLDSKVSGNYN; AGICASYQTQTKSHR; YFASIEKSNIIRGWI; KLDSKVSGNYNYLYR; ASYQTQTKSHRRARS;IEKSNIIRGWIFGTT; KVSGNYNYLYRLFRK; TQTKSHRRARSVASQ; CEFQFCNDPFLDHKN; FERDISTEIYQAGNK; SHRRARSVASQSIIA; FCNDPFLDHKNNKSW;ISTEIYQAGNKPCNG; LLLQYGSFCTQLKRA; PFLDHKNNKSWMESE; IYQAGNKPCNGVAGF; YGSFCTQLKRALTGI; DGYFKIYSKHTPIIV; GNKPCNGVAGFNCYF;CTQLKRALTGIAVEQ; KIYSKHTPIIVREPE; CNGVAGFNCYFPLKS; KRALTGIAVEQDKNT; KHTPIIVREPEDLPQ; AGFNCYFPLKSYSFR; QVKQIYKTPPIKYFG;IIVREPEDLPQGFSA; CYFPLKSYSFRPTYG; IYKTPPIKYFGGFNF; EPEDLPQGFSALEPL; LKSYSFRPTYGVGHQ; PPIKYFGGFNFSQIL; RFPNITNLCPFDEVF;SFRPTYGVGHQPYRV; YFGGFNFSQILPDPS; ITNLCPFDEVFNATR; TYGVGHQPYRVVVLS; IAARDLICAQKFKGL; CPFDEVFNATRFASV; GHQPYRVVVLSFELL;DLICAQKFKGLTVLP; NCVADYSVLYNLAPF; NKCVNFNFNGLKGTG; AQKFKGLTVLPPLLT; DYSVLYNLAPFFTFK; NFNFNGLKGTGVLTE; KGLTVLPPLLTDEMI;LYNLAPFFTFKCYGV; NGLKGTGVLTESNKK; STASALGKLQDVVNH; APFFTFKCYGVSPTK; PGTNTSNQVAVLYQG; ALGKLQDVVNHNAQA; GDEVRQIAPGQTGNI;TSNQVAVLYQGVNCT; LQDVVNHNAQALNTL; VNHNAQALNTLVKQL; AQALNTLVKQLSSKF; NTLVKQLSSKFGAIS; KQLSSKFGAISSVLN; SKFGAISSVLNDIFS;AISSVLNDIFSRLDK; VLNDIFSRLDKVEAE; IFSRLDKVEAEVQID

This peptide pool of the omicron variant of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) that covers the whole spike glycoprotein with all mutations. Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.The peptides of this product are supplied lyophilized as trifluoro acetate salts. Peptide Scan 15/11Length: 1270 amino acidsMFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLKSYGFQPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT

This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020. Data from the RKI (Germany): India, Oct. 2020: G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H. Possible applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide purified by solid phase extraction and purity checked by ESI-MS. Peptide sequences included (each with 25µg):KVCEFQFCNDPFLDV NGVQGFNCYFPLQSY PAHEKNFTTAPAICH FQFCNDPFLDVYYHK GTNTSNQVAVLYQGV NDPFLDVYYHKNNKS SNQVAVLYQGVNCTE LDVYYHKNNKSWMKS AVLYQGVNCTEVPVA YHKNNKSWMKSEFRV QGVNCTEVPVAIHAD NKSWMKSEFRVYSSA GICASYQTQTNSRRR MKSEFRVYSSANNCT SYQTQTNSRRRARSV LDSKVGGNYNYRYRL QTNSRRRARSVASQS VGGNYNYRYRLFRKS RRRARSVASQSIIAY YNYRYRLFRKSNLKP PHGVVFLHVTYVPAH YQAGSTPCNGVQGFN VFLHVTYVPAHEKNF STPCNGVQGFNCYFP VTYVPAHEKNFTTAP Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. Protein ID: P0DTC2 (swiss prot)  

SARS-CoV-2 (Spike Glycoprotein) Peptide Pool of 316 overlapping peptides (delivered in two subpools of 158 & 158 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P0DTC2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). Complete protein sequence of Spike (or Surface) Glycoprotein, Gene name: S (each peptide with about 25µg) MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT Dissolve in a minimum amount of pure DMSO (approx. 80µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. UniProt: P0DTC2

The Variant B.1.617.2 (Delta) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) with 27 peptides covers all mutations in the Spike Glycoprotein derived from the delta variant B.1.617.2 of SARS-CoV-2 which is prevalent in India and carries the L452R spike mutation, among others. Possilbe applications:  T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide purity checked by ESI-MS and purifed by solid phase extraction. Peptide sequences included (each peptide with 25µg)YHKNNKSWMESEVYS STEIYQAGSKPCNGV TASALGKLQNVVNQN NKSWMESEVYSSANN YQAGSKPCNGVEGFNLGKLQNVVNQNAQAL MESEVYSSANNCTFE SKPCNGVEGFNCYFP QNVVNQNAQALNTLV VYSSANNCTFEYVSQGTNTSNQVAVLYQGV LVLLPLVSSQCVNLR SNQVAVLYQGVNCTE PLVSSQCVNLRTRTQ AVLYQGVNCTEVPVASQCVNLRTRTQLPPA QGVNCTEVPVAIHAD NLRTRTQLPPAYTNS GICASYQTQTNSRRR LDSKVGGNYNYRYRLSYQTQTNSRRRARSV VGGNYNYRYRLFRKS QTNSRRRARSVASQS YNYRYRLFRKSNLKP RRRARSVASQSIIAYERDISTEIYQAGSKP SLSSTASALGKLQNV Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. Protein ID: P0DTC2 (swiss prot)

SARS-CoV-2 Nucleocapsid KCYGVSPTK with amino acids 138-146 of the Nucleocapsid protein is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Nucleocapsid A1 peptide with amino acids LTDEMIAQY of the Nucleocapsid protein is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Surface A2 peptide with amino acids YLQPRTFLL of the Nucleocapsid protein is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Nucleocapsid _3 B7 KPRQKRTAT is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Nucleocapsid _2 B7 SPRWYFYYL is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Nucleocapsid _1 B7 FPRGQGVPI is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Nucleocapsid A2 peptide LLLDRLNQLwith amino acids N223-231 of the Nucleocapsid protein is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Membrane GP A2 TLACFVLAAV with amino acids 61-70 of the Membrane GP A2 protein is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Nucleocapsid A2 peptide LALLLLDRL with amino acids 226-234 of the Nucleocapsid protein is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays

SARS-CoV-2 Nucleocapsid A2 peptide LQLPQGTTL with amino acids 219-227 of the Nucleocapsid protein is an antigen-specific SARS-CoV-2 peptide. Applications for SARS-CoV-2 peptides include, but are not limited to: SARS-CoV-2 T cell stimulationSARS-CoV-2 immune monitoring (Covid19 immune monitoring)SARS-CoV-2 epitope discoverySARS-CoV-2 target discoverySARS-CoV-2 T cell assays